Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00553839 · ClinicalTrials.gov registry record · NA
Pharmacokinetics of Ketamine in Infants and Children
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT00553839: Completed NA study, sponsored by Stanford University.
NCT00553839 is a NA study that has completed, run by Stanford University. The registered enrollment target is 21 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00553839, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
Dosing of medications is based on the plasma level achieved with a given dose and how long the medicine remains in the body. This study is called pharmacokinetics-that is, what the body does to the medication. Ketamine is an intravenous medication used for anesthesia and sedation in children. However the pharmacokinetics of Ketamine has not been systematically studied. We propose to study the pharmacokinetics of ketamine in different age groups of children ranging from infants to teenagers.
Interventions
- DRUG ketamine hydrochloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2007-07 |
| Est. Completion | 2009-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00553839
The ClinicalTrials.gov registry entry for NCT00553839 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ketamine hydrochloride is the first listed.
NCT00553839 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00553839 about?
NCT00553839 is a clinical study titled "Pharmacokinetics of Ketamine in Infants and Children". Dosing of medications is based on the plasma level achieved with a given dose and how long the medicine remains in the body. This study is called pharmacokinetics-that is, what the body does to the medication. Ketamine is an intravenous medication used for anesthesia and sedation in children. Howeve...
What is the current status of trial NCT00553839?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2007-07. Estimated completion is 2009-01.
What interventions are being tested in trial NCT00553839?
The interventions under investigation include: ketamine hydrochloride (DRUG).
Who is sponsoring clinical trial NCT00553839?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.